Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
F2G raised a $100m round co-led AMR Action Fund and ICG, joined by Novo, Advent Life, Sofinnova, Forbion, Blue Owl, Morningside, and Merifin Capital.

F2G raised a $100m round co-led AMR Action Fund and ICG, joined by Novo, Advent Life, Sofinnova, Forbion, Blue Owl, Morningside, and Merifin Capital.

Biotech Health services Pharma

Denmark

France

United Kingdom

Netherlands

United States

Belgium

Investments

01 September 2024

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

F2G (company)

United Kingdom

Biotech Health services Pharma

Total investments received (USD): 170M

Round value (USD): 100M

Round investors: Advent Life Sciences Blue Owl Capital Novo A/S Intermediate Capital Group Forbion Capital Partners AMR Action Fund Morningside Ventures Brace Pharma Capital Merifin Capital Sofinnova Partners

Company: F2G

Industry: Biotech Health services Pharma

Related deals

Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Health services Manufacturing Pharma

Sweden

Switzerland

France

United Kingdom

Netherlands

United States

Investments 07 November 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top